For #doctors trying to stay abreast of the latest #medical breakthroughs, reviewing the latest research is like being shot in the face with a water cannon. A new paper is published every 30 seconds. Trying to comb through it all to come up with a diagnosis or treatment plan that reflects the best current options while seeing 20 patients a day is a near-impossible task. “We talk about the golden age of biotechnology where there are new drugs and better drugs developed all the time. But it is like the dark ages for physicians because of burnout,” Daniel Nadler, cofounder and CEO of #OpenEvidence, told Forbes. “There is this enormous firehose of information they need to stay on top of, and the human brain is limited in its capacity to read millions of studies.” So Nadler, 42, a Harvard Ph.D. who sold his previous company for $550 million back in 2018, set out to solve the problem with artificial intelligence. At the link in our bio, read about how this #AI founder became a billionaire ...